A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
56
Participants
Timeline
Start Date
December 31, 2011
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Conditions
Healthy Volunteer
Interventions
DRUG
RO4917523
orally daily, 14 days
DRUG
RO5011232
\[11C\]-RO5011232 intravenously
Trial Locations (2)
21224
Baltimore
21225
Baltimore
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT01483469 - A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy Volunteers | Biotech Hunter | Biotech Hunter